94 related articles for article (PubMed ID: 31858684)
1. Response to: USP26 regulates TGF-β signalling by deubiquitinating and stabilizing SMAD7; not applicable in glioblastoma.
Kit Leng Lui S; Iyengar PV; Jaynes P; Isa ZFBA; Pang B; Tan TZ; Eichhorn PJA
EMBO Rep; 2020 Jan; 21(1):e47269. PubMed ID: 31858684
[TBL] [Abstract][Full Text] [Related]
2. USP26 regulates TGF-β signalling by deubiquitinating and stabilizing SMAD7; not applicable in glioblastoma.
Ware TM; Zhu HJ
EMBO Rep; 2020 Jan; 21(1):e47030. PubMed ID: 31858693
[TBL] [Abstract][Full Text] [Related]
3. USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7.
Kit Leng Lui S; Iyengar PV; Jaynes P; Isa ZFBA; Pang B; Tan TZ; Eichhorn PJA
EMBO Rep; 2017 May; 18(5):797-808. PubMed ID: 28381482
[TBL] [Abstract][Full Text] [Related]
4. P144, a Transforming Growth Factor beta inhibitor peptide, generates antitumoral effects and modifies SMAD7 and SKI levels in human glioblastoma cell lines.
Gallo-Oller G; Vollmann-Zwerenz A; Meléndez B; Rey JA; Hau P; Dotor J; Castresana JS
Cancer Lett; 2016 Oct; 381(1):67-75. PubMed ID: 27473823
[TBL] [Abstract][Full Text] [Related]
5. Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling.
Yan X; Chen YG
Biochem J; 2011 Feb; 434(1):1-10. PubMed ID: 21269274
[TBL] [Abstract][Full Text] [Related]
6. USP26 regulates TGF-β signaling by deubiquitinating and stabilizing SMAD7.
Kit Leng Lui S; Iyengar PV; Jaynes P; Isa ZFBA; Pang B; Tan TZ; Eichhorn PJA
EMBO Rep; 2020 Jan; 21(1):e49618. PubMed ID: 31910334
[No Abstract] [Full Text] [Related]
7. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway.
Liu N; Jiao T; Huang Y; Liu W; Li Z; Ye X
J Virol; 2015 Mar; 89(5):2739-49. PubMed ID: 25540364
[TBL] [Abstract][Full Text] [Related]
9. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
Bizet AA; Tran-Khanh N; Saksena A; Liu K; Buschmann MD; Philip A
J Cell Biochem; 2012 Jan; 113(1):238-46. PubMed ID: 21898545
[TBL] [Abstract][Full Text] [Related]
10. The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling.
Wicks SJ; Haros K; Maillard M; Song L; Cohen RE; Dijke PT; Chantry A
Oncogene; 2005 Dec; 24(54):8080-4. PubMed ID: 16027725
[TBL] [Abstract][Full Text] [Related]
11. Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7.
Koinuma D; Shinozaki M; Komuro A; Goto K; Saitoh M; Hanyu A; Ebina M; Nukiwa T; Miyazawa K; Imamura T; Miyazono K
EMBO J; 2003 Dec; 22(24):6458-70. PubMed ID: 14657019
[TBL] [Abstract][Full Text] [Related]
12. Crk-associated substrate lymphocyte type regulates transforming growth factor-beta signaling by inhibiting Smad6 and Smad7.
Inamoto S; Iwata S; Inamoto T; Nomura S; Sasaki T; Urasaki Y; Hosono O; Kawasaki H; Tanaka H; Dang NH; Morimoto C
Oncogene; 2007 Feb; 26(6):893-904. PubMed ID: 16909115
[TBL] [Abstract][Full Text] [Related]
13. Smad7 in TGF-beta-mediated negative regulation of gut inflammation.
Monteleone G; Pallone F; MacDonald TT
Trends Immunol; 2004 Oct; 25(10):513-7. PubMed ID: 15364052
[TBL] [Abstract][Full Text] [Related]
14. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.
Edlund S; Bu S; Schuster N; Aspenström P; Heuchel R; Heldin NE; ten Dijke P; Heldin CH; Landström M
Mol Biol Cell; 2003 Feb; 14(2):529-44. PubMed ID: 12589052
[TBL] [Abstract][Full Text] [Related]
16. Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells.
Landström M; Heldin NE; Bu S; Hermansson A; Itoh S; ten Dijke P; Heldin CH
Curr Biol; 2000 May; 10(9):535-8. PubMed ID: 10801443
[TBL] [Abstract][Full Text] [Related]
17. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
[TBL] [Abstract][Full Text] [Related]
18. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory Smad7: emerging roles in health and disease.
Briones-Orta MA; Tecalco-Cruz AC; Sosa-Garrocho M; Caligaris C; Macías-Silva M
Curr Mol Pharmacol; 2011 Jun; 4(2):141-53. PubMed ID: 21222648
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of transforming growth factor-beta (TGF-beta) signaling by WW domain-containing protein 1 (WWP1).
Komuro A; Imamura T; Saitoh M; Yoshida Y; Yamori T; Miyazono K; Miyazawa K
Oncogene; 2004 Sep; 23(41):6914-23. PubMed ID: 15221015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
